Björn E. Groenemeijer
Björn E. Groenemeijer publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism, on topics such as Lipoproteins and Cardiovascular Health, Antiplatelet Therapy and Cardiovascular Diseases and Atrial Fibrillation Management and Outcomes.
- World rank
- #667,324 of 7,710,434 ranked researchers
- Rank in Netherlands
- #16,093 of 107,149
- Works
- 36
- Citations
- 3k
- Citations per work
- 84.4
What does Björn E. Groenemeijer research?
Björn E. Groenemeijer's work is mostly in Medicine (74%), Economics, Econometrics and Finance (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2774.5%
- Medicine2774.5%
- Everything else720.6%
- Social Sciences24.9%
- 1Cardiology and Cardiovascular Medicine32% of their works
- 2Surgery20% of their works
- 3Endocrinology, Diabetes and Metabolism13% of their works
- 4Epidemiology6% of their works
- 5Economics and Econometrics5% of their works
- 6Pulmonary and Respiratory Medicine4% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Acute Myocardial Infarction Research
- Lipid metabolism and disorders
- Diabetes Treatment and Management
- Cardiovascular Function and Risk Factors
Which keywords describe Björn E. Groenemeijer's research?
The keywords of their largest research topics: Cholesterol-lowering, Statins, Cardiovascular Disease, Guidelines, Metabolic Syndrome, Obesity, Aspirin and Clopidogrel.
- Chamber Quantification
- Myocardial Infarction
- Cardiovascular Outcomes
- ANGPTL3
- Diabetes
- Anticoagulant Therapy
- Clopidogrel
- Obesity
- Guidelines
- Statins
- Cholesterol-lowering
- Cardiovascular Disease
- Metabolic Syndrome
- Aspirin
- Heart Failure
- Atrial Fibrillation
- Insulin Resistance
- Acute Coronary Syndromes
- Lipoprotein Lipase
- Type 2 Diabetes
- Echocardiography
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Cholesterol-lowering151 topic
- Statins151 topic
- Cardiovascular Disease102 topics
- Guidelines102 topics
- Metabolic Syndrome102 topics
- Obesity92 topics
- Aspirin71 topic
- Clopidogrel71 topic
- Heart Failure72 topics
- Anticoagulant Therapy61 topic
- Atrial Fibrillation61 topic
- Diabetes61 topic
- Insulin Resistance61 topic
- ANGPTL341 topic
- Acute Coronary Syndromes41 topic
- Cardiovascular Outcomes41 topic
- Lipoprotein Lipase41 topic
- Myocardial Infarction41 topic
- Type 2 Diabetes41 topic
- Chamber Quantification31 topic
- Echocardiography31 topic
Where does Björn E. Groenemeijer work?
Björn E. Groenemeijer's main affiliation in the publication record is Gelre Hospitals, Netherlands.
How many publications and citations does Björn E. Groenemeijer have?
OpenAlex counts 36 works and 3,039 citations for Björn E. Groenemeijer, an h-index of 17, ranking #667,324 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Björn E. Groenemeijer. Posts are plain text and can be reported.